Estrella Immunopharma, Inc. Quarterly Assets in USD from Q3 2021 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Estrella Immunopharma, Inc. quarterly Assets history and growth rate from Q3 2021 to Q2 2024.
Estrella Immunopharma, Inc. Assets for the quarter ending June 30, 2024 was $4.45M, a 47.1% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$4.45M	+$1.43M	+47.1%	Jun 30, 2024	10-K	2024-09-27
Q1 2024	$8.63M	-$1.15M	-11.7%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$9.45M	-$277K	-2.84%	Dec 31, 2023	10-Q	2024-02-14
Q3 2023	$27.3M	-$18.3M	-40%	Sep 30, 2023	10-Q	2023-11-20
Q2 2023	$3.03M	-$42.4M	-93.3%	Jun 30, 2023	10-K	2024-09-27
Q1 2023	$9.78M	-$35.8M	-78.6%	Mar 31, 2023	10-Q	2023-05-18
Q4 2022	$9.72M	-$36.1M	-78.8%	Dec 31, 2022	10-Q	2023-08-01
Q3 2022	$45.6M	-$346K	-0.75%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$45.4M			Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$45.6M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$45.8M			Dec 31, 2021	10-K	2023-03-14
Q3 2021	$46M			Sep 30, 2021	10-Q	2021-11-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.